The M&A market in 2026 is producing a paradox that dealmakers at every level should be watching closely. While overall deal volume remains subdued compared to the frenzied pace of 2021, the sheer scale of the transactions getting done has shifted dramatically upward. Through the first quarter, deals valued above $1 billion are up 57% year over year, with 22 transactions of that size announced compared to just 14 during the same window in 2025.
This is not simply a return to normal after a slow period. It represents a structural shift in how the largest companies and most aggressive sponsors are deploying capital, and its ripple effects are reaching well beyond the Fortune 500.
The logic driving megadeals in 2026 centers on capability acquisition rather than incremental market share. Companies are no longer content to build internally what they can buy at scale. Abbott's roughly $21 billion acquisition of Exact Sciences is a case in point: rather than spending years developing a competitive diagnostics platform, Abbott chose to acquire a leader outright, gaining both the technology and the commercial infrastructure in a single move.
This pattern is repeating across sectors. In technology, AI infrastructure has become the most contested terrain, with acquirers paying premium valuations for companies that control data center capacity, cooling systems, and power management. In energy, BlackRock's Global Infrastructure Partners and EQT jointly announced a $10.7 billion deal for AES Corporation, consolidating renewable energy assets at a scale that smaller competitors simply cannot match.
The common thread is speed. In markets where first-mover advantages compound quickly (AI, energy transition, precision diagnostics), acquirers are concluding that the cost of waiting exceeds the cost of paying a premium.
Several factors are channeling capital toward the largest transactions. First, private equity firms are sitting on an estimated $2.1 to $2.6 trillion in global dry powder, a figure that creates intense pressure to deploy. For the largest funds, writing checks below $500 million simply does not move the needle on deployment targets. The result is a natural gravitational pull toward bigger deals.
Second, financing conditions, while not as accommodating as they were in 2020 and 2021, have stabilized enough to support large leveraged transactions. Syndicated loan markets are functioning well, and direct lenders have expanded their capacity to underwrite deals that would have been bank-only territory a few years ago.
Third, corporate boards are increasingly comfortable with transformative acquisitions. After several years of cautious, bolt-on strategies, the C-suite appetite for large-scale transactions has returned, driven by competitive pressure and the recognition that organic growth alone may not keep pace with market shifts.

Business owners operating in the $10 million to $500 million enterprise value range might view megadeals as irrelevant to their world, but the effects are more direct than they appear.
When a sector experiences a wave of large-scale consolidation, it typically triggers secondary deal activity as the acquiring companies rationalize overlapping operations, divest non-core assets, and seek tuck-in acquisitions to fill gaps exposed during integration. These secondary transactions often land squarely in the middle market.
Additionally, megadeal multiples tend to reset valuation expectations across an industry. When a healthcare services platform trades at 14x EBITDA in a billion-dollar deal, comparable companies at lower revenue thresholds often see their own valuation benchmarks shift upward. This can be a double-edged sword: while sellers benefit from higher implied valuations, buyers become more cautious about overpaying, and quality of earnings scrutiny intensifies.
Technology remains the dominant sector for megadeal activity, with roughly 25% of all deal value concentrated in tech and AI-enabled infrastructure. The OpenAI joint venture discussions with TPG, Brookfield, and Bain Capital, structured around a $10 billion pre-money valuation, illustrate the scale of capital flowing toward AI-adjacent businesses.
Healthcare is the second most active sector, driven by consolidation in diagnostics, specialty pharma, and healthcare IT. Energy and infrastructure rank third, with the energy transition creating opportunities for large-scale asset aggregation that appeals to both strategic and financial buyers.
Notably, industrial and manufacturing megadeals have picked up as well, partly because tariff-related supply chain realignments are prompting companies to acquire domestic production capacity rather than build it from scratch.
The 2026 megadeal surge reflects a fundamental shift in how the largest market participants are competing, with speed-to-capability replacing incremental growth as the dominant strategic priority. For business owners and investors at every level, these transactions are reshaping industry structures, recalibrating valuation expectations, and accelerating the pace of change. The companies that understand these dynamics and prepare accordingly will be best positioned to capitalize on the opportunities they create.